BOUNDLESS BIO, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2023 | — | $-127.1M | $23.7M |
| FY2024 | — | $150.6M | $26.6M |
| FY2025 | — | $98.7M | $17.9M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2023 | — | $-127.1M | $23.7M |
| FY2024 | — | $150.6M | $26.6M |
| FY2025 | — | $98.7M | $17.9M |